![Gordon Brooks](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Gordon J.
Brooks currently works at Dermira, Inc., as Director from 2020, ARMO BioSciences, Inc., as Director from 2018, and Sigilon Therapeutics, Inc., as Director from 2023.
Cargos activos de Gordon Brooks
| Empresas | Cargo | Inicio |
|---|---|---|
| ARMO BIOSCIENCES INC | Director/Miembro de la Junta | 21/06/2018 |
| DERMIRA, INC. | Director/Miembro de la Junta | 20/02/2020 |
| SIGILON THERAPEUTICS, INC. | Director/Miembro de la Junta | 11/08/2023 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
48
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
- Bolsa de valores
- Insiders
- Gordon Brooks
